Smith Alan K. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jul 5, 2018
Insider Transaction Report
Form 4
Smith Alan K.
EVP, Technical Oprations
Transactions
- Award
Stock Option (right to buy)
2018-07-02+39,375→ 39,375 totalExercise: $7.72Exp: 2028-07-01→ Common Stock (39,375 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.